Accumulate Jyothy Labs: Parag Parikh

Published on Tue, Feb 09, 2010 at 12:52 |  Source : Moneycontrol.com

Updated at Fri, Jul 30, 2010 at 17:25  

4828 Investors following Jyothy Laboratories. Share this News with them.
0
0
Share on Tumblr
Accumulate Jyothy Labs: Parag Parikh

ALSO READ

Parag Parikh Research has recommended accumulate rating on Jyothy Laboratories , in its February 08, 2010 research report.

"Last week, Jyothy Laboratories Ltd. (JLL) announced an agreement with DRDO (Defense Research & Development Organization) for a mosquito repellant product. DRDO has a special mosquito repellant which is at present used specifically for the protection of military personnel. Keeping in mind the various mosquito related life-threatening diseases spreading across the country, DRDO now wants to make this product available for the masses."

"At the CMP of Rs.161.05, the stock trades at 15.9x FY10E and 12.8x FY11E. Our view is that, with these favorable developments happening in the core business alongwith caution being observed on the JFSL front, the Company is poised strongly for the years ahead. We recommend an Accumulate."

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment

  

More on Moneycontrol

Trending News

Business News

Government to directly check BBM and other IM services
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com